Semantic Scholar uses AI to extract papers important to this topic.
This study sought to assess the long-term clinical consequences of reocclusion after coronary thrombolysis… Expand Tissue plasminogen activator (tPA), an approved coronary thrombolytic agent, can cause serious bleeding. We report the cases of… Expand Abstract Building upon elucidation of fundamental aspects of the pathogenesis of myocardial infarction and the fibrinolytic… Expand Platelet activation is markedly increased during coronary thrombolysis and limits the response to thrombolytic therapy. A… Expand Dilation of the left ventricle after myocardial infarction is common, occurs rapidly (within 2 weeks of infarction) and may be… Expand The long-term prognosis after thrombolytic therapy in patients with acute myocardial infarction (AMI) is unknown. This question… Expand Thirty-four patients with acute myocardial infarction were treated prospectively using a new strategy of prehospital intravenous… Expand WHEN the editorial offices of Circulation moved to St. Louis, a series of "Perspectives" was initiated. The first, published in… Expand Anterior ST segment depression, found in 13 of 17 patients with acute inferior myocardial infarctions, resolved promptly in all… Expand To delineate beneficial effects of intracoronary thrombolysis on myocardial metabolism in vivo and their dependence on the… Expand